GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bionet Corp (ROCO:1784) » Definitions » Cyclically Adjusted Revenue per Share

Bionet (ROCO:1784) Cyclically Adjusted Revenue per Share : NT$19.24 (As of Mar. 2025)


View and export this data going back to 2007. Start your Free Trial

What is Bionet Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bionet's adjusted revenue per share for the three months ended in Mar. 2025 was NT$5.723. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$19.24 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Bionet's average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Bionet was 8.00% per year. The lowest was 7.10% per year. And the median was 7.30% per year.

As of today (2025-05-30), Bionet's current stock price is NT$70.80. Bionet's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was NT$19.24. Bionet's Cyclically Adjusted PS Ratio of today is 3.68.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bionet was 7.48. The lowest was 1.77. And the median was 2.72.


Bionet Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Bionet's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionet Cyclically Adjusted Revenue per Share Chart

Bionet Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.77 15.18 16.25 17.35 18.75

Bionet Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.90 18.17 18.47 18.75 19.24

Competitive Comparison of Bionet's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, Bionet's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bionet's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bionet's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bionet's Cyclically Adjusted PS Ratio falls into.


;
;

Bionet Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bionet's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=5.723/134.9266*134.9266
=5.723

Current CPI (Mar. 2025) = 134.9266.

Bionet Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 3.151 100.684 4.223
201509 2.806 100.392 3.771
201512 2.928 99.792 3.959
201603 2.883 100.470 3.872
201606 2.919 101.688 3.873
201609 3.685 101.861 4.881
201612 3.022 101.863 4.003
201703 3.051 102.862 4.002
201706 2.992 103.349 3.906
201709 2.948 104.136 3.820
201712 3.455 104.011 4.482
201803 3.385 105.290 4.338
201806 3.380 106.317 4.290
201809 3.506 106.507 4.442
201812 3.905 105.998 4.971
201903 3.378 107.251 4.250
201906 3.294 108.070 4.113
201909 3.536 108.329 4.404
201912 3.746 108.420 4.662
202003 3.686 108.902 4.567
202006 3.464 108.767 4.297
202009 3.606 109.815 4.431
202012 4.110 109.897 5.046
202103 4.339 111.754 5.239
202106 4.643 114.631 5.465
202109 4.166 115.734 4.857
202112 4.128 117.630 4.735
202203 4.313 121.301 4.797
202206 4.599 125.017 4.964
202209 4.769 125.227 5.138
202212 4.993 125.222 5.380
202303 4.913 127.348 5.205
202306 5.880 128.729 6.163
202309 5.584 129.860 5.802
202312 5.666 129.419 5.907
202403 5.832 131.776 5.971
202406 5.696 132.554 5.798
202409 6.011 133.029 6.097
202412 6.449 133.157 6.535
202503 5.723 134.927 5.723

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Bionet  (ROCO:1784) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bionet's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=70.80/19.24
=3.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bionet was 7.48. The lowest was 1.77. And the median was 2.72.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bionet Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Bionet's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bionet Business Description

Industry
Traded in Other Exchanges
N/A
Address
No.28, Lane 36, Xinhu 1st Road, Neihu District, Taipei, TWN, 114065
Bionet Corp provides blood bank and stem cell services. It is a preservation center for stem cells such as Umbilical Cord Mesenchymal Stem Cells and Dental Pulp Stem Cell Stem.

Bionet Headlines

No Headlines